Charles V. Baltic III, Director at MEI Pharma, Inc. (MEIP), bought 10,200 shares at $6.25 ($62K) on 2013-01-25, disclosed to the SEC on 2013-01-29.
Open-market purchase of $62k MEIP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.75 | 80 | $460 | 0.7% |
| 2 | $5.90 | 5,920 | $35K | 56.7% |
| 3 | $6.25 | 4,200 | $26K | 42.6% |
| Total | $6.04 avg | 10,200 | $62K | 100% |
| Filing → |
| MEIP | SELL | 2017-11-29 | $24K | — | Filing → |
| MEIP | BUY | 2015-01-23 | $19K | — | Filing → |
| MEIP | BUY | 2015-01-02 | $13K | — | Filing → |